Asia·Sep 15, 2026
India's Chinese Import Bill Climbs Despite Self-Reliance Push
New Delhi's manufacturing drive has yet to curb dependence on electronics, machinery and chemical inputs from across the Himalayas
By Priyanka V. Rao · 3 min ·
Tag
Pharmaceuticals
Every BriefAsia story tagged Pharmaceuticals, newest first.
Asia·Aug 31, 2026
China Shifts Pharma Strategy From Manufacturing to Drug Ownership
Two recent developments in Jiangsu province signal Beijing's push beyond contract production toward controlling intellectual property in the pharmaceutical sector
By Priyanka V. Rao · 3 min ·
Finance·Aug 31, 2026
Samsung Biologics Plans $2.2 Billion Rights Offering to Fund Peptide Acquisition
South Korean contract manufacturer will issue 2.27 million new shares at discounted price as pharmaceutical industry consolidation accelerates
By Jun-ho Seo · 3 min ·
Technology·Aug 22, 2026
Japan Launches First Oncolytic Virus Therapy for Esophageal Cancer
Oncolys BioPharma's genetically modified virus treatment marks a new frontier in cancer therapeutics across Asia
By Aiko Nakamura · 3 min ·
Asia·Aug 17, 2026
Singapore Export Growth Slows to 24% as AI Chip Boom Fails to Meet Expectations
Electronics shipments more than doubled in July, but overall trade performance fell short of economist forecasts amid pharmaceutical sector weakness
By Priyanka V. Rao · 4 min ·
Asia·Aug 15, 2026
Hong Kong Positions Itself as Asia's Next Biotech Research Hub
A recent summit drew 3,000 attendees as the city leverages its regional connectivity to attract global pharmaceutical investment and clinical trial infrastructure.
By Priyanka V. Rao · 2 min ·
Finance·Aug 13, 2026
Malaysian Healthcare Group Posts Triple Net Profit on Debt Reduction Strategy
Pharmaniaga's quarterly earnings surge reflects aggressive deleveraging and a landmark insulin contract that positions the firm for biopharmaceutical expansion across Southeast Asia
By Priyanka V. Rao · 5 min ·
Finance·Aug 10, 2026
Celltrion Sets Second Straight Revenue Record as Brokerages Lift Price Targets
Korean biopharma's Q2 profit jumped 86% on stronger biosimilar demand, pushing operating margin past 32% for the first time
By Jun-ho Seo · 3 min ·
Asia·Aug 8, 2026
Pentagon's Chinese Military Blacklist Temporarily Blocked for WuXi AppTec
Federal judge grants injunction after finding insufficient justification for biotechnology firm's designation
By Cheng Wei-Lun · 3 min ·
Finance·Aug 5, 2026
Alteogen Secures $365 Million Licensing Deal for Subcutaneous Drug Platform
Korean biotech firm signs exclusive agreement with global pharma partner to commercialize proprietary enzyme technology for biologic drug delivery
By Cheng Wei-Lun · 3 min ·
Technology·Aug 3, 2026
Korean Botulinum Maker Daewoong Claims Regional Lead with Kuwait Market Entry
Nabota now operates across seven Middle Eastern markets, marking the widest footprint among South Korean toxin brands in the region
By Cheng Wei-Lun · 3 min ·
Asia·Jul 31, 2026
Roche and Zuellig Pharma Extend Philippines Distribution Partnership Into Sixth Decade
The Swiss pharmaceutical giant and Asia's largest healthcare distributor have renewed their collaboration, securing supply continuity for oncology and rare disease treatments across the archipelago.
By Priyanka V. Rao · 3 min ·
Asia·Jul 30, 2026
SK Biopharm Takes Epilepsy Drug to Brazil in Latin America Expansion
South Korean pharmaceutical company signs distribution deal with Eurofarma as CEO joins presidential trade delegation for first time
By Priyanka V. Rao · 3 min ·
Technology·Jul 28, 2026
South Korean Peptide Maker Files Vasopressin API With US Regulators
HLB Pep's Drug Master File registration marks a strategic step in the company's bid to supply critical-care ingredients to American pharmaceutical manufacturers
By Cheng Wei-Lun · 3 min ·
Asia·Jul 27, 2026
Pakistan Signs $850 Million Pharmaceutical Deals With Chinese Companies
Agreements span vaccine production, medical devices, and API manufacturing as Islamabad moves to reduce import dependence and build domestic capacity
By Priyanka V. Rao · 3 min ·
Asia·Jul 24, 2026
Malaysia Braces for Ripple Effects from US Generic Drug Tariff Plan
Washington's proposal to impose up to 200 percent tariffs on imported pharmaceuticals threatens to disrupt supply chains across Asia, even in markets with minimal direct exposure.
By Priyanka V. Rao · 4 min ·
Asia·Jul 23, 2026
Trump's 100% Tariff Threat Targets Indian Generic Drug Exporters
Two-year ultimatum demands pharmaceutical production shift to U.S. soil or face import duties that could double by 2028
By Priyanka V. Rao · 3 min ·
Finance·Jul 20, 2026
Samsung Biologics Offers $1.8 Billion for Swiss Peptide Manufacturer
The South Korean biotech giant aims to expand into obesity and diabetes drug production through the all-cash acquisition of PolyPeptide
By Cheng Wei-Lun · 3 min ·
Asia·Jul 9, 2026
Hong Kong Races to Build Independent Drug Approval System by 2030
City targets WHO recognition for its Centre for Medical Products Regulation as it pivots from reliance on foreign approvals to primary evaluation hub
By Priyanka V. Rao · 4 min ·
Finance·Jul 3, 2026
Sun Pharmaceutical Posts 10.5% Quarterly Gain as India Pharma Rally Extends
The Mumbai-based drugmaker recorded positive returns across multiple timeframes, with trading volumes nearing recent averages amid sustained investor interest in Indian pharmaceutical equities.
By Priyanka V. Rao · 3 min ·